SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-16-019249
Filing Date
2016-05-12
Accepted
2016-05-12 16:33:47
Documents
4
Period of Report
2016-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kmph-8k_20160512.htm 8-K 35203
2 EX-99.1 kmph-ex991_6.htm EX-99.1 287960
3 GRAPHIC ggghyoc3gcec000001.jpg GRAPHIC 1727
4 GRAPHIC ggghyoc3gcec000002.jpg GRAPHIC 3070
  Complete submission text file 0001564590-16-019249.txt   331280
Mailing Address 2656 CROSSPARK ROAD, SUITE 100 CORALVILLE IA 52241
Business Address 2656 CROSSPARK ROAD, SUITE 100 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 161644447
SIC: 2834 Pharmaceutical Preparations